InVivoMAb anti-human/monkey MHC class II (HLA-DR)

Brentville VA, Metheringham RL, Gunn B, et al. Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity. Cancer Res. 2016,76(3):548-60. doi: 10.1158/0008-5472.CAN-15-1085

Hirasawa M, Hagihara K, Okudaira N, et al. The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01. PLoS One. 2015,10(6):e0130928. doi: 10.1371/journal.pone.0130928

Kho S, Marfurt J, Noviyanti R, et al. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection. Infect Immun. 2015,83(8):3224-32. doi: 10.1128/IAI.00226-15

Kalka-Moll WM, Tzianabos AO, Bryant PW, et al. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol. 2002,169(11):6149-53.

Esser MT, Graham DR, Coren LV, et al. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J Virol. 2001,75(13):6173-82.

Goodier MR, Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. J Immunol. 2000,165(1):139-47.